Searched for
PHARMACOVIGILANCE MARKET
Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- Drug regulator cracks down on delayed safety reporting by pharma companiesIndia's drug regulator CDSCO has issued new rules for drug safety reporting. Companies must now submit safety reports from the actual launc...
- India tightens grip on GLP-1 supply chain amid misuse concerns, expands crackdown on unapproved drugsIndia's drug regulator is increasing checks on weight loss drug sales. This action follows inspections of pharmacies and clinics nationwide...
- Pharma firms asked for side-effects of common medicinesIndia's drug regulator has issued new safety warnings for common medicines. Doxycycline, an antibiotic, will now list side effects like anx...
- Graph AI raises $3 million seed funding for drug safety platformAI life sciences startup Graph AI has secured $3 million in seed funding to revolutionise pharmacovigilance. The California-based startup l...
- Govt issues guidance paper to strengthen vaccine companies' reporting of adverse eventsThe new report released last week aims to provide guidance to the manufacturers and importers of vaccines in the country so as to strengthe...
- Lupin appoints Dr Ranjana Pathak as chief quality officerDr. Ranjana Pathak appointed Lupin's chief quality officer, succeeding Johnny Mikell. With 30 years of experience, she led quality at Cipla...
- Eris enters JV with MJ Pharma to commercialise insulins in domestic marketThe business of the joint venture will be kickstarted with the launch of human insulin in the fourth quarter of FY22.
- Now, antacids must carry ‘kidney injury’ warningNow the anti-acidity pills will carry a side-effect warning of 'acute kidney injury' as a part of their package insert leaflets, following ...
- HCL Technologies acquires C3i Solutions for $60 millionC3i Solutions is a wholly owned, independently operated subsidiary of Merck & Co, (known as MSD outside the US and Canada).
- Health ministry okays plan to monitor medical devices; vigilance cells to be set up nationwideTo begin with, MvPI cells are to be established in 10 medical colleges. These will be funded by the government to report online.
- Pharma companies may have to report drugs’ side effects to regulatorIndia is set to make it mandatory for pharmaceutical firms to report side effects of drugs to the regulator.
- Ban proposed on drugs having serious side effects"There are variations in each individual in conversions of codeine to morphine and each individual reacts differently," Prof K C Singhal.
- Sun Pharma signs pact with Merck; stock gainsTildrakizumab is currently being evaluated in Phase 3 registration trials for the treatment of chronic plaque psoriasis, a skin ailment.
- TCS, Cognizant, Wipro, Accenture, Genpact, HCL bite into drug safetyIndustry experts say that pharmacovigilance & clinical data management is growing at feverish pace with some pegging the growth rate at 100...
- Indian pharmaceutical industry to reach $20 bn by 2015: AssochamAssocham has said it expects the Indian pharmaceutical industry to reach $20 billion by 2015, making it one of the world's top 10 pharmaceu...
- Centre may tighten quality check on drugsThe government may make it compulsory for all hospitals and medical institutions to report adverse drug reactions, a move, which could enab...
- TCS eyes deals in life sciences, healthcare spaceLife sciences and healthcare is the sixth-largest vertical for TCS and accounted for 5.2% of the firm’s revenues at the end of fiscal year ...
- Accenture to expand lifesciences R&D unitWith global pharma companies waking up to technology outsourcing services as a tool to reduce the time to market of their R&D harvest.
Load More
